Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Aragon Pharmaceuticals Inc patents


Recent patent applications related to Aragon Pharmaceuticals Inc. Aragon Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Aragon Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Aragon Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Aragon Pharmaceuticals Inc-related inventors


Processes for the preparation of a diarylthiohydantoin compound

Disclosed are processes and intermediates for the preparation of compound (x), which is currently being investigated for the treatment of prostate cancer.. . ... Aragon Pharmaceuticals Inc

Anticancer compositions

The present invention concerns pharmaceutical formulations of arn-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (ar)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemically relapsed hormone sensitive prostate cancer, or high-risk, non-metastatic castration-resistant prostate cancer. In one aspect, these formulations comprise a solid dispersion of arn-509 and hpmcas. ... Aragon Pharmaceuticals Inc

Anticancer compositions

The present invention concerns pharmaceutical formulations of arn-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (ar)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemically relapsed hormone sensitive prostate cancer, or high-risk, non-metastatic castration-resistant prostate cancer. In one aspect, these formulations comprise a solid dispersion of arn-509, a poly(meth)acrylate copolymer and hpmcas. ... Aragon Pharmaceuticals Inc

Anticancer compositions

The present invention concerns pharmaceutical formulations of arn-509, which can be administered to a mammal, in particular a human, suffering from an androgen receptor (ar)-related disease or condition, in particular cancer, more in particular prostate cancer, including but not limited to castration-resistant prostate cancer, metastatic castration resistant prostate cancer, chemotherapy-naive metastatic castration resistant prostate cancer, biochemically relapsed hormone sensitive prostate cancer, or high-risk, non-metastatic castration-resistant prostate cancer. In one aspect, these formulations comprise a solid dispersion of arn-509 and a poly(meth)acrylate copolymer. ... Aragon Pharmaceuticals Inc

Methods and compositions for determining resistance to androgen receptor therapy

Described herein are modified androgen receptor polypeptides that are resistant to inhibition by an androgen receptor inhibitor. Described herein are compositions, combinations, and kits containing the modified androgen receptor polypeptides and methods of using the modified androgen receptor polypeptides. ... Aragon Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Aragon Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Aragon Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###